argenx SE — News

$865 USD

$0 (0.0%)

Source	Headline
	Argenx's Vyvgart sales jump in second quarter Belgian-Dutch immunology company argenx said on Thursday global sales of its lead ‌drug Vyvgart jumped in the second quarter of 2026 from a year earlier. reuters.com - 2026-07-23 01:41:31
	Sanofi, An Argenx Rival, Bites The Dust — But A Third Biotech Took The Biggest Hit Sanofi scrapped a final-phase study Wednesday of an experimental CIDP treatment. The stock tumbled in response. investors.com - 2026-06-10 10:15:51
	argenx SE (ARGX) Q1 2026 Earnings Call Transcript argenx SE (ARGX) Q1 2026 Earnings Call Transcript seekingalpha.com - 2026-05-07 17:11:21

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

Last Month

0 analysts

Last Quarter

0 analysts

Last Year

0 analysts

All Time

0 analysts

Date	Analyst Firm	Action	Previous Grade	New Grade
2023-10-01	Truist Securities	Maintain	Buy	Buy
2023-09-17	HC Wainwright & Co.	Maintain	Buy	Buy
2023-08-30	Piper Sandler	Maintain	Overweight	Overweight
2023-07-27	Wells Fargo	Maintain	Overweight	Overweight
2023-07-27	HC Wainwright & Co.	Maintain	Buy	Buy
2023-07-27	Guggenheim	Maintain	Buy	Buy
2023-07-23	Piper Sandler	Maintain	Overweight	Overweight
2023-07-23	UBS	Downgrade	Buy	Neutral
2023-07-20	HC Wainwright & Co.	Maintain	Buy	Buy
2023-07-19	Morgan Stanley	Maintain	Overweight	Overweight
2023-07-17	HC Wainwright & Co.	Maintain	Buy	Buy
2023-07-17	Raymond James	Maintain	Strong Buy	Strong Buy
2023-07-17	Citigroup	Maintain	Buy	Buy
2023-07-17	Guggenheim	Maintain	Buy	Buy
2023-07-17	Wedbush	Maintain	Outperform	Outperform
2023-07-16	Jefferies	Maintain	Buy	Buy
2023-07-16	HC Wainwright & Co.	Maintain	Buy	Buy
2023-06-21	HC Wainwright & Co.	Maintain	Buy	Buy
2023-06-20	HC Wainwright & Co.	Maintain	Buy	Buy
2023-06-20	Wedbush	Maintain	Outperform	Outperform
2023-06-06	HC Wainwright & Co.	Maintain	Buy	Buy
2023-05-04	Truist Securities	Maintain	Buy	Buy
2023-05-04	JMP Securities	Maintain	Market Outperform	Market Outperform
2023-05-04	Morgan Stanley	Maintain	Overweight	Overweight
2023-05-04	HC Wainwright & Co.	Maintain	Buy	Buy
2023-05-04	Raymond James	Maintain	Strong Buy	Strong Buy
2023-03-19	HC Wainwright & Co.	Maintain	Buy	Buy
2023-03-02	JMP Securities	Maintain	Market Outperform	Market Outperform
2023-03-02	SVB Leerink	Maintain	Outperform	Outperform
2023-02-22	Piper Sandler	Maintain	Overweight	Overweight